Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.
Pernilla DarlingtonMari RoëlMaria CronhjortGabriel HannaAnders HedmanEva Joelsson-AlmAnna SchandlPublished in: BMJ open (2023)
This study indicates that even though intensive care treatment strategies have changed with time, there are few differences in long-term HRQL and respiratory health seems to remain at 6 months for patients surviving critical COVID-19 in the first and second/third waves of the pandemic.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- public health
- pulmonary hypertension
- mental health
- prognostic factors
- type diabetes
- respiratory syndrome coronavirus
- early onset
- metabolic syndrome
- risk assessment
- adipose tissue
- human health
- social media
- insulin resistance
- glycemic control